United States · FDA National Drug Code directory
NYSTATIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64950-372_319a98e0-8009-47c9-9f40-9cd288c26e48
- Product NDC
- 64950-372
- Form
- SUSPENSION
- Composition / generic term
- NYSTATIN
- Labeler
- Genus Lifesciences Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260324
- Source listing expiry
- 20271231
Source-listed ingredients
- NYSTATIN — 100000 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 60 mL in 1 BOTTLE, DROPPER (64950-372-06) · 64950-372-06
- 473 mL in 1 BOTTLE (64950-372-47) · 64950-372-47
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →